Accelerated high-dose radiation for early breast cancer
Part of Cancer, Skin clinical trials.
This trial tests a very short, high-dose radiation treatment given directly to the breast after lumpectomy. It aims to make radiation more convenient by finishing in just a few days instead of weeks, possibly with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 45 and 79 years old.
- You have a new diagnosis of early-stage breast cancer (non-invasive or invasive, tumor size up to 3 cm).
- You have already had a lumpectomy that removed all cancer tissue with clear surgical margins.
- You have no cancer in your lymph nodes (or you are age 70+ with a low-risk tumor and willing to take an aromatase inhibitor).
- You have not had any prior breast or chest radiation, and you have not had breast cancer before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a one-time radiation treatment given directly to the area where your breast cancer was removed. It aims to reduce the need for multiple radiation sessions and may be an option for certain patients with early-stage breast cancer.
This trial tests a shorter, more intense course of daily radiation therapy (called ultra hypo-fractionation) given after lumpectomy for early-stage breast cancer. The goal is to reduce the number of treatment visits while keeping the same high level of effectiveness and safety.
This trial compares two different radiation doses (30 Gy versus 26 Gy) given in five sessions after a lumpectomy to treat early-stage breast cancer. The goal is to see whether the lower dose works just as well with fewer side effects and better quality of life.
This trial tests whether a shorter, 3-day course of partial breast radiation after surgery works as well as standard radiation for women with early-stage breast cancer. It may help reduce time in treatment while aiming to keep cancer from coming back in the treated breast area.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This trial tests giving a single, very targeted dose of radiation right after surgery for early-stage breast cancer. It is for women age 40+ with small, low-risk tumors (Luminal A or B) that have been fully removed and have not spread to lymph nodes.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.